FDA-approved
Skin & aging
Dalbavancin / Oritavancin / Telavancin
Evidence
FDA approved
Class
Lipoglycopeptide antibiotics
KEY TAKEAWAY
These are three related antibiotics built on the structure of vancomycin, with added lipid chains that help them last longer. They are sold as Dalvance, Orbactiv and Vibativ. All three are FDA-approved for acute bacterial skin and skin structure infections. Telavancin is also approved for certain pneumonias.
Written by the Veylo editorial team · Updated
November 2026
What it is
Lipoglycopeptide antibiotics
Approved for
Serious skin infections caused by gram-positive bacteria, including MRSA
Key fact
All three are FDA-approved for acute bacterial skin and skin structure infections. Telavancin is also approved for certain pneumonias.
Route
Intravenous infusion
Evidence strength
FDA approved
These are three related antibiotics built on the structure of vancomycin, with added lipid chains that help them last longer. They are sold as Dalvance, Orbactiv and Vibativ.
They block bacteria from building cell walls. Oritavancin and telavancin also damage the bacterial membrane.
All three are FDA-approved for acute bacterial skin and skin structure infections. Telavancin is also approved for certain pneumonias.
Serious skin infections caused by gram-positive bacteria, including MRSA.
Side effects vary by drug and include nausea, headache and infusion reactions. Telavancin carries boxed warnings for kidney injury and risk to a fetus.
U.S. FDA prescribing information for Dalbavancin / Oritavancin / Telavancin. DailyMed, National Library of Medicine.
Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.